Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium.
Saved in:
| Title: | Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium. |
|---|---|
| Authors: | Curran, K.J.1,2 (AUTHOR), Fabrizio, V.A.1,2 (AUTHOR), Mauguen, A.1 (AUTHOR), Boelens, J.J.3 (AUTHOR), Baggott, C.4 (AUTHOR), Prabhu, S.4 (AUTHOR), Placenta, H.5 (AUTHOR), Phillips, C.L.6 (AUTHOR), Rossoff, J.7 (AUTHOR), Stefanski, H.8 (AUTHOR), Talano, J.9 (AUTHOR), Moskop, A.9 (AUTHOR), Margossian, S.P.10,11 (AUTHOR), Verneris, M.R.12 (AUTHOR), Myers, G.13 (AUTHOR), Karras, N.A.14 (AUTHOR), Brown, P.A.15 (AUTHOR), Qayed, M.16 (AUTHOR), Hermiston, M.17 (AUTHOR), Satwani, P.18 (AUTHOR) |
| Source: | Cytotherapy (Elsevier Inc.). 2021 Supplement, Vol. 23 Issue 5, pS27-S27. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 150257420 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Curran%2C+K%2EJ%2E%22">Curran, K.J.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fabrizio%2C+V%2EA%2E%22">Fabrizio, V.A.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mauguen%2C+A%2E%22">Mauguen, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boelens%2C+J%2EJ%2E%22">Boelens, J.J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baggott%2C+C%2E%22">Baggott, C.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Prabhu%2C+S%2E%22">Prabhu, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Placenta%2C+H%2E%22">Placenta, H.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Phillips%2C+C%2EL%2E%22">Phillips, C.L.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rossoff%2C+J%2E%22">Rossoff, J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stefanski%2C+H%2E%22">Stefanski, H.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Talano%2C+J%2E%22">Talano, J.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moskop%2C+A%2E%22">Moskop, A.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Margossian%2C+S%2EP%2E%22">Margossian, S.P.</searchLink><relatesTo>10,11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verneris%2C+M%2ER%2E%22">Verneris, M.R.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Myers%2C+G%2E%22">Myers, G.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karras%2C+N%2EA%2E%22">Karras, N.A.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brown%2C+P%2EA%2E%22">Brown, P.A.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qayed%2C+M%2E%22">Qayed, M.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hermiston%2C+M%2E%22">Hermiston, M.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Satwani%2C+P%2E%22">Satwani, P.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cytotherapy+%28Elsevier+Inc%2E%29%22">Cytotherapy (Elsevier Inc.)</searchLink>. 2021 Supplement, Vol. 23 Issue 5, pS27-S27. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=150257420 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1465324921002899 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S27 Titles: – TitleFull: Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Curran, K.J. – PersonEntity: Name: NameFull: Fabrizio, V.A. – PersonEntity: Name: NameFull: Mauguen, A. – PersonEntity: Name: NameFull: Boelens, J.J. – PersonEntity: Name: NameFull: Baggott, C. – PersonEntity: Name: NameFull: Prabhu, S. – PersonEntity: Name: NameFull: Placenta, H. – PersonEntity: Name: NameFull: Phillips, C.L. – PersonEntity: Name: NameFull: Rossoff, J. – PersonEntity: Name: NameFull: Stefanski, H. – PersonEntity: Name: NameFull: Talano, J. – PersonEntity: Name: NameFull: Moskop, A. – PersonEntity: Name: NameFull: Margossian, S.P. – PersonEntity: Name: NameFull: Verneris, M.R. – PersonEntity: Name: NameFull: Myers, G. – PersonEntity: Name: NameFull: Karras, N.A. – PersonEntity: Name: NameFull: Brown, P.A. – PersonEntity: Name: NameFull: Qayed, M. – PersonEntity: Name: NameFull: Hermiston, M. – PersonEntity: Name: NameFull: Satwani, P. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 05 Text: 2021 Supplement Type: published Y: 2021 Identifiers: – Type: issn-print Value: 14653249 Numbering: – Type: volume Value: 23 – Type: issue Value: 5 Titles: – TitleFull: Cytotherapy (Elsevier Inc.) Type: main |
| ResultId | 1 |
